Connection

Andrew Jakymiw to RNA, Small Interfering

This is a "connection" page, showing publications Andrew Jakymiw has written about RNA, Small Interfering.
Connection Strength

1.938
  1. Peptide carriers to the rescue: overcoming the barriers to siRNA delivery for cancer treatment. Transl Res. 2019 12; 214:92-104.
    View in: PubMed
    Score: 0.566
  2. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncol. 2017 09; 72:123-131.
    View in: PubMed
    Score: 0.492
  3. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. J Control Release. 2015 Nov 28; 218:72-81.
    View in: PubMed
    Score: 0.433
  4. Fusogenic-oligoarginine peptide-mediated delivery of siRNAs targeting the CIP2A oncogene into oral cancer cells. PLoS One. 2013; 8(9):e73348.
    View in: PubMed
    Score: 0.376
  5. Disruption of GW bodies impairs mammalian RNA interference. Nat Cell Biol. 2005 Dec; 7(12):1267-74.
    View in: PubMed
    Score: 0.055
  6. AAV-mediated knockdown of phospholamban leads to improved contractility and calcium handling in cardiomyocytes. J Gene Med. 2008 Feb; 10(2):132-42.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.